Literature DB >> 164970

A comparison of phosphate bone-scanning agents in normal subjects and patients with malignant disease.

D L Citrin, R G Bessent, J B Tuohy, S T elms, E McGinlay, W R Greig, L Blumgart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 164970     DOI: 10.1259/0007-1285-48-566-118

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  7 in total

1.  Early detection of metastatic breast cancer using new bone scanning agents.

Authors:  D L Citrin; R G Bessent; L H Blumgart; W R Greig
Journal:  Proc R Soc Med       Date:  1975-06

2.  A clinical comparison of 2 h and 4 h bone scans obtained with 99Tc H.E.D.P.

Authors:  I Fogelman; C Goll; J H McKillop; D L Citrin; W R Greig
Journal:  Eur J Nucl Med       Date:  1978

Review 3.  Skeletal uptake of diphosphonate: a review.

Authors:  I Fogelman
Journal:  Eur J Nucl Med       Date:  1980-12

Review 4.  Skeletal scintigraphy.

Authors:  I R McDougall
Journal:  West J Med       Date:  1979-06

5.  Diphosphonate bone scanning agents--current concepts.

Authors:  I Fogelman
Journal:  Eur J Nucl Med       Date:  1982

6.  The clinical comparison of skeletal imaging agents.

Authors:  F G Adams; P W Horton; G Stenhouse
Journal:  Eur J Nucl Med       Date:  1980-06

7.  Advances in drug design of radiometal-based imaging agents for bone disorders.

Authors:  Kazuma Ogawa; Hideo Saji
Journal:  Int J Mol Imaging       Date:  2011-12-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.